Johns Hopkins Medicine study uncovers enzyme inhibitor that boosts immune system to fight MRSA and other dangerous skin infections
Researchers suggest that faecal microbiota transplant (FMT) might be worth exploring as a treatment option for coronavirus.
Scientists at the University of Cambridge have identified rare genetic variants – carried by one in 3,000 people – that have a larger impact on the risk of developing type 2 diabetes than any previously identified genetic effect.
Research published today has demonstrated the viability of 3D-printed tissue scaffolds that harmlessly degrade while promoting tissue regeneration following implantation.
Designed from the yeast used to make beer, ‘Y-bots’ can target inflammation, tissue scarring and disturbances in the balance of microbes living in the gut
For the first time, researchers have convincing evidence that a medicine for celiac disease can be found. In an international study, a drug candidate called ZED1227 was able to inhibit the activity of transglutaminase 2 (TG2) which triggers celiac disease pathogenesis mechanisms in the mucosa that lines the small intestine.